XML 23 R14.htm IDEA: XBRL DOCUMENT
v3.22.1

Note 8 - Accrued Expenses | 3 Months Ended
--- | ---
Mar. 31, 2022
Notes to Financial Statements |
Accounts Payable and Accrued Liabilities Disclosure [Text Block] |
8. | Accrued Expenses
Accrued expenses consist of the following:
|  | March 31, 2022 |  |  | December 31, 2021 |
Compensation and related expenses |  | $ | 7,457 |  |  | $ | 9,523 |
Professional fees |  |  | 2,967 |  |  |  | 3,590 |
Operating lease liability - current |  |  | 1,528 |  |  |  | 1,526 |
Clinical trial costs |  |  | 2,014 |  |  |  | 1,961 |
Financing lease liability - current |  |  | 122 |  |  |  | 188 |
Other |  |  | 1,145 |  |  |  | 1,059 |
Total |  | $ | 15,233 |  |  | $ | 17,847 |

X
- Definition The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a),20,24) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration